Pacific Biosciences raises $50m in sixth round of funding by bringing in Nasdaq-listed healthcare diagnostic company Gen-Probe.
Nasdaq-listed healthcare diagnostic company Gen-Probe has made its largest corporate venture-style investment by funding a $50m series F round for biotechnology company Pacific Biosciences.
Excluding the latest round, US-based Pacific raised additional, undisclosed money from its existing venture capital and strategic investors that have provided $261m in funding since its launch in 2004.
Gen-Probe’s investment comes with an exclusive collaboration for 30 months "with the goal of developing a longer-term, preferred business relationship aimed toward improving the diagnosis of human…